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Mammalian liver tyrosine transaminase (L-tyro- 
sine: 2-oxoglutarate aminotransferase) has been wide- 
ly used as a model to study glucocorticoid hormone 
specific gene modulation. Additionally, the manner in 
which this system responds is often employed ‘to 
delineate factors controlling gene expression during: 
pathogenesis [l] , shock [2] , stress [3] , circadian 
rhythms [4]; change in metabolic status after growth 
hormone [5,6], glucose [7], insulin [8], glucagon 
[7] , irradiation or starvation [9] , anaesthesia [lo] ; 
growth of hepatoma cells in culture [ II] , or isolated 
liver cells [ 121; liver regeneration [ 131, foetal differ- 
entiation [ 141, and neoplastic transformation in rat he- 
patomas [ 151. In view of this popularity, it becomes 
important to establish valid procedures to measure 
liver tyrosine transaminase (TT) levels. 
The activity of hepatic TT is commonly measured 
by a calorimetric procedure where the development 
of a blue colour is proportional to the concentration 
of p-hydroxyphenylpyruvic acid (PHPP), in a manner 
analogous to the Fiske-Subbarow reaction for inor- 
ganic phosphate [ 161. In the course of an investiga- 
tion on adaptive enzyme changes in liver, selected 
tryptophan metabolites were found to interfere with 
this calorimetric method in vitro. The results are 
described here with a view to preventing inadvertent 
future errors. 
The enzyme preparation was obtained by homo- 
genizing mouse liver in 9 vol of ice cold 0.14 M KCl, 
0.0025 M NaOH. All other chemicals were reagent 
grade and were used without further purification. 
The standard reaction was carried out as follows: a 
buffer-substrate reagent for 30 flasks, prepared just 
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before use by mixing from individual, refrigerated 
stock solutions, contained 75 ml of 0.25 M sucrose; 
18 ml of 0.1 M o-ketoglutaric acid (dissolved in 
0.25 M NaHz P04, pH 7.4); 15 ml of 0.2 M phosphate 
buffer, pH 7.4; 6 ml of 2.8 mM pyridoxal phosphate; 
and 0.6 ml of 0.5 M diethyldithiocarbamate (DDC). 
To 3.8 ml of this solution were added 0.6 ml enzyme 
preparation in a 30 ml Erlenmeyer flask. After 3 min 
incubation at 38°C in a water bath, 1.2 ml of 0.01 M 
L-tyrosine were added. Incubation was carried on for 
an additional 10 min. The reaction was stopped by 
adding 0.6 ml 100% trichloroacetic acid (TCA). Mix- 
tures were shaken immediately and filtered through 
Whatman No. 1 paper. A series of standard flasks 
contained 100-300 pg PHPP. 
The calorimetric reaction was carried out as fol- 
lows: to 2 ml of filtrates from blank, experimental 
and standard flasks was added 4 ml of the colour 
reagent (which consisted of: 0.75 ml of a 3% solution 
of ammonium heptamolybdata in 5N HCl; 1.25 ml of 
a 1% solution of KHZ PO4 and 1.6 ml distilled water). 
The mixtures were shaken vigorously and then allowed 
to stand for 30 min at room temperature. The intensi- 
ty of the blue colour was determined by absorbance 
at 850 nm. 
Data in table 1 show that 5-hydroxytryptophan 
and 5-hydroxytryptamine (serotonin) were nearly 
equally effective in causing a 3-fold increase in TT 
activity in vitro. Tryptophan, phenylalanine (which 
also contains an aromatic residue) and its derivatives 
para-chlorophenylalanine and 3,4-hydroxyphenyl- 
alanine (DOPA), and the long chain aliphatic amino 
acid leucine - all appeared ineffective in altering TT 
activity in vitro. So, the kinetics of this in vitro ‘acti- 
vation’ was measured with tryptophan and its analo- 
gues. 
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Table 1 
Specificity of indole ring analogues in altering the calorimetric 
assay for ‘IT activity 
1.6 
Addition + At350 1.2 
Water 0.235 
Tryptophan 0.287 
5-Hydroxytryptophan 0.689 
Serotonin 0.728 
Phenylalanine 0.203 
3, 4-Hydroxyphenylalanine 0.251 
p-Chlorophenylalanine 0.275 
Leucine 0.293 
+ All materials (lmg) were added in a volume of 0.2 ml to the 
standard assay for ‘M as described in the text. Each value is 
the average of three separate determinations. 
The intensity of TT reaction increased with pro- 
gressively larger quantities (O-5 mg) of either 5-hy- 
droxytryptophan or serotonin in vitro (fig. l), al- 
though the recovery of exogenously added PHPP was 
already linear with 100-300 pg of the enzyme prod- 
uct. An effect of tryptophan was not noticeable 
under these conditions (data not shown). It was next 
determined whether these materials altered the 
catalytic activity of the enzyme template or the de- 
velopment of colour in the ammonium heptamolyb- 
date - KHaPO., reaction. 
JJ~ PHPP 
100 200 300 
1.2 - 
,” 0.8- 
aD 
4 
I I I I 
1 2 3 4 5 
mg product 
Fig. 1. In vitro influence of tryptophan analogues on liver 
tyrosine transaminase activity. Details of a standard assay are 
given in the text. The tryptophan (o), S-hydroxytryptophan 
(0) or serotonin (A) were dissolved in distilled water and the 
indicated amounts were added in a volume of 0.2 ml at the 
beginning of incubation. Flasks maintained as blands (m), or 
those containing the PHPP standard (0) received only dis- 
tilled water. All values represent average of determinations on 
three separate enzyme preparations. 
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Fig. 2. Interference by tryptophan analogues of Briggs colour 
reaction for tyrosine transminase activity. Procedure for 
Briggs colour reaction has been described in the text. To 4 ml 
of the colour reagent were added increasing amounts of sero- 
tonin (n), tryptophan (o) or 5-hydroxytryptophan (A), in a 
volume of 0.2 ml. A standard curve with PHPP was run at the 
same time (0). The samples were mixed thoroughly and the 
intensity of colour was measured 30 min later at 850 nm. All 
values represent average of three separate determinations. 
As evident from fig. 2, addition of either Shy- 
droxytryptophan or serotonin served to produce a 
product with strong absorption at 850 nm. However, 
quantitatively these compounds were not as specific 
as PHPP, and conceivably these materials could have 
an additive effect. Thus, reduction of phosphomolyb- 
die acid to form a coloured complex is not specific to 
PHPP, although the latter may do so preferentially. 
Liver TT activity may be measured by any one of 
a number of procedures. In the method of Diamond- 
stone [ 171 , the concentration of PHPP is assessed by 
its conversion to p-hydroxybenzaldehyde (PHBA), in 
presence of strong alkali, with an absorption maxima 
at 33 1 nm. This procedure suffers from the drawback 
that DDC (used to inhibit PHPP oxidase) absorbs 
strongly at 33 1 nm; the blanks are even higher 
(around 1 .O), and very unstable, if TCA is used to 
precipitate protein. Moreover, the reaction requires 
high speed supernantant fractions which makes it 
impractical to process large numbers of individual 
samples. In the enolborate procedure [ 181, the in- 
crease in absorbance at 3 10 nm must be followed 
with time. Furthermore, tautomerase (for conversion 
of keto PHPP to the enol form) must be added sepa- 
rately under certain conditions. Although less sensi- 
tive than other assays, the chief advantages of the 
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modified Briggs calorimetric procedure (as employed 
here) are its overall simplicity and reliability as a 
fixed time assay for TT activity [ 191 . 
In an earlier report [20], serotonin and 5-hy- 
droxytryptophan were shown to produce 6-fold in- 
duction in rat liver TT, as measured by the Briggs 
calorimetric procedure. The limited effectiveness of 
tryptophan in these in vivo experiments can most 
easily be explained by its hydroxylation and subse- 
quent decarboxylation to products which would in- 
terfere with the phosphomolybdic reaction in vitro, 
as shown in this report. Since serotonin and 5-hy- 
droxytryptophan were equally effective, and since 
tryptophan was inactive, it is clear that the ability to 
reduce the phosphomolybdic acid must reside in 
modification at the 5 position of the indole ring. The 
manner in which this is accomplished remains un- 
known. A comparative study with other techniques is 
required to assess whether these tryptophan analo- 
gues would indeed alter TT regulation in vivo. 
In any event, it is obvious that the term ‘induc- 
tion’ should be employed only when all evidence 
points to an increase in the amounts of protein moi- 
ties. Thus, in future it becomes imperative to test the 
influence of a substance in vitro before attempting to 
arrive at a mechanism of the manner in which a 
change (either increase or decrease) may accompany 
administration of the substance in vivo. 
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